Every Form 4 that CareCloud, Inc. 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (CCLDO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CCLDO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CCLDO filings page.
CareCloud, Inc. Chief Executive Officer Stephen Andrew Snyder reported a disposition of 30,790 shares of the company’s Series B Cumulative Redeemable Perpetual Preferred Stock. The shares were removed from his direct holdings at a price of $25.25 per share, leaving him with zero shares of this preferred series.
According to the disclosure, this transaction was carried out through a mandatory redemption of the Series B Preferred Stock by the issuer and was not an open market sale initiated by Snyder.
CareCloud, Inc. interim CFO and Controller Norman Roth reported a mandatory redemption of 6,500 shares of the company’s Series B Cumulative Redeemable Perpetual Preferred Stock. The shares were disposed of at $25.25 per share in a transaction classified as a disposition to the issuer, not an open market sale, leaving no remaining holdings of this preferred security.
CareCloud, Inc. director Bill Korn reported a disposition of 10,800 shares of the company’s Series B Cumulative Redeemable Perpetual Preferred Stock. The shares were transferred back to the issuer at $25.25 per share through a mandatory redemption, and his reported holdings of this preferred stock are now zero.
The transaction was characterized as a disposition to the issuer rather than an open market sale, indicating the redemption was driven by the security’s terms rather than an individual trading decision.
CareCloud, Inc. Chief Strategy Officer A Hadi Chaudhry reported a mandatory redemption of 7,800 shares of Series B Cumulative Redeemable Perpetual Preferred Stock at $25.25 per share. The shares were disposed of back to the issuer, and the reporting person now holds 0 shares of this security.
CareCloud director Lawrence S. Sharnak reported an equity award vesting and share issuance. On February 8, 2026, 7,500 restricted stock units converted into 7,500 shares of CareCloud common stock at a price of $0. According to the filing, these restricted stock units and the resulting shares were granted under the company’s Amended and Restated Equity Incentive Plan without payment by Sharnak.
Following the transaction, Sharnak directly owned 127,750 shares of common stock and 26,250 restricted stock units. This reflects routine compensation-related activity rather than an open-market purchase or sale.
CareCloud, Inc. director Cameron Munter reported a routine equity compensation vesting. On February 8, 2026, 7,500 restricted stock units converted into 7,500 shares of common stock at a price of $0 per share, under the company’s Amended and Restated Equity Incentive Plan.
After this conversion, Munter directly beneficially owned 202,750 shares of CareCloud common stock and 26,250 restricted stock units. The transaction involved no cash payment by the reporting person and reflects standard compensation-based vesting rather than an open‑market purchase or sale.
CareCloud, Inc. director Anne Busquet reported the vesting and conversion of 7,500 restricted stock units into common stock on February 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without any cash payment by her.
After this equity award vesting, she directly holds 295,138 shares of CareCloud common stock and 26,250 derivative securities in the form of restricted stock units.
CareCloud, Inc. director Bill Korn reported the vesting and conversion of 7,500 restricted stock units into common stock on February 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without any cash payment by Korn.
After this transaction, Korn beneficially owns 211,633 shares of CareCloud common stock directly and 26,250 restricted stock units, reflecting his ongoing equity-based compensation as a director.
CareCloud, Inc. director Bill Korn reported the vesting of equity awards and related share issuance. On January 31, 2026, 6,250 restricted stock units converted into 6,250 shares of common stock at a price of $0.00 under the company’s Amended and Restated Equity Incentive Plan, without payment by Korn. Following this transaction, he directly owned 204,133 shares of common stock and 33,750 restricted stock units.
CareCloud, Inc. director Anne Busquet reported a routine equity award vesting and conversion. On January 31, 2026, 6,250 restricted stock units vested and converted into 6,250 shares of common stock at a price of $0.00 under the company’s Amended and Restated Equity Incentive Plan, without payment by Busquet.
After this transaction, she directly holds 287,638 shares of common stock and 33,750 restricted stock units, reflecting ongoing participation in CareCloud’s long‑term incentive program rather than an open‑market purchase or sale.
CareCloud director Lawrence Steven Sharnak reported the vesting of equity awards and related share issuance. On January 31, 2026, 6,250 restricted stock units converted into 6,250 shares of CareCloud common stock at a price of $0 per share under the company’s Amended and Restated Equity Incentive Plan.
After this transaction, Sharnak directly owned 120,250 shares of common stock and 33,750 restricted stock units. The award vested without cash payment by the reporting person, reflecting compensation delivered in company equity rather than cash.
CareCloud, Inc. director Cameron Munter reported the vesting and conversion of restricted stock units into common stock. On January 31, 2026, 6,250 restricted stock units converted into 6,250 shares of common stock at a price of $0.00 under CareCloud’s Amended and Restated Equity Incentive Plan, without payment by Munter.
After this transaction, Munter directly owned 195,250 shares of CareCloud common stock and 33,750 restricted stock units. The filing reflects equity-based compensation vesting rather than an open‑market purchase or sale.